Gongji Pregnancy Endocrine Cohort
Official title: Serological, Metabolomic, and Genomic Studies of Endocrine Disorders in Pregnancy
Run by Shanghai General Hospital, China · NCT07125885 · Data updated 2026-11-12
This project will try to see how genes, lifestyle, and medications relate to gestational diabetes and thyroid problems and their effects on pregnancy and the first year after birth for women planning pregnancy, pregnant, or within one year postpartum.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 3000 (estimated) |
| Sponsor | Shanghai General Hospital, China Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | May 5, 2023 |
| Main results expected | December 31, 2043 |
| Study ends | December 31, 2043 |
| Registry record updated | August 15, 2025 |
| Trial ID | NCT07125885 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 or older who are preparing for pregnancy, currently pregnant, or within one year after giving birth and who consent to follow‑up are ideal candidates.
✕Probably not a fit
Pregnant women with severe organic diseases or serious mental illness, individuals unable to communicate normally, or those unwilling to cooperate are excluded and would not participate or benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational cohort combining prospective and retrospective data collection at Shanghai General Hospital. Researchers will collect genetic information, lifestyle factors, and records of any drug treatments, then link those data to the occurrence and progression of gestational endocrine conditions and to pregnancy and postpartum maternal‑infant outcomes. Eligible participants are adult women planning pregnancy, currently pregnant, or within one year after delivery who sign informed consent. No investigational interventions are given as part of the study; participants undergo follow‑up and data collection only.
Why it matters
Potential benefit: If successful, the study could help identify genetic and modifiable risk factors to guide prevention and personalized management and reduce adverse pregnancy and postpartum outcomes.
How similar studies have gone: Other cohort studies have linked genetics, lifestyle, and treatment patterns to gestational diabetes and thyroid disorders and have produced useful risk markers, though each new cohort adds population‑specific detail.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women preparing for pregnancy or pregnant women or within 1 year after giving birth * Age ≥ 18 years old * Signed the informed consent form to voluntarily enroll in the management follow-up Exclusion Criteria: * Individuals who are unable to communicate normally and those who are unwilling to cooperate * Pregnant women with severe organic diseases or mental illnesses * Any condition deemed by the investigator to affect eligibility for the study
Where it's running
-
Shanghai General Hospital, China
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Yufan Wang, PhD
- Email: yyffwang@sina.com
- Phone: (+86) 021-63240090
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Shanghai cohort for high blood sugar during pregnancy
This project will follow pregnant people with high blood sugar or at high risk for gestational diabetes to test subtype-specific standards for diagnosis, treatment, and follow-up from before pregnancy through postpartum.
-
Core Canister Training for pregnant women with gestational diabetes
A randomized trial tests whether a structured core canister training program helps pregnant women with a history of gestational diabetes improve abdominal and pelvic muscle strength and stability.
-
Lumbopelvic Stability in Gestational Diabetes Mellitus
This study tests whether gestational diabetes affects lumbopelvic stability during mid-pregnancy in first-time mothers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.